# Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/incorporation-of-anti-angiogenesis-therapy-in-the-management-of-advanced-ovarian/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ramez N. Eskander,Krishnansu S. Tewari |
| Citations | 130 |
| DOI | 10.1016/j.ygyno.2013.11.029 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://escholarship.org/uc/item/0112v2kx |
| OpenAlex ID | https://openalex.org/W1994701350 |
| PMID | 24316305 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Ramez N. Eskander](https://scholariq.org/researchers/ramez-n-eskander/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.